News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|August 18, 2012

COMING SOON: Biosimilars: Overview of the FDA Draft Guidance Documents [Presentation]

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC commentary

Biosimilar Interchangeability and Substitution in the US: What Comes Next?

ByBenjamin N. Rome, MD, MPH,Anushka Bhaskar, MPhil,Aaron S. Kesselheim, MD, JD, MPH

October 30th 2025

Marky Markary, MD, Robert F. Kennedy, Jr, and Mehmet Oz, MD

FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development

BySkylar Jeremias

October 29th 2025

AJMC original research clinical

The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance

BySamantha R. Paglinco, DO,Mahmoud Abdel-Rasoul, MS, MPH,Megan McNicol, PharmD, BCACP,Morgane C. Mouslim, DVM, ScM,Brendan Boyle, MD,Jennifer L. Dotson, MD, MPH,Hilary K. Michel, MD,Ross M. Maltz, MD

October 14th 2025

Dr Sophia Humphreys

Oncology Care Model Promotes High-Quality, Cost-Conscious Cancer Treatment: Sophia Humphreys, PharmD, MHA, BCBBS

ByBrooke McCormick,Sophia Humphreys, PharmD, MHA, BCBBS

October 2nd 2025

Integrating AI and Pathway Flexibility to Advance Value-Based Cancer Care: Clayton Irvine, PharmD, MBA, MS

ByClayton Irvine, PharmD, MBA, MS,Alana Hippensteele, MA

August 14th 2025

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text